Drug application
MYCIFRADIN (NEOMYCIN SULFATE)
Drugs@FDA NDA 050285 · PHARMACIA AND UPJOHN
Key facts
| Drug name | MYCIFRADIN |
|---|---|
| Active ingredients | NEOMYCIN SULFATE |
| Application type | NDA |
| Application number | 050285 |
| Company | PHARMACIA AND UPJOHN |
| Dosage forms | SOLUTION, ORAL |
| Strength | EQ 87.5MG BASE/5ML |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission status date | Mar 13, 2009 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.